Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Artisan Partners

Artisan Small Cap Fund Investor Shares (ARTSX)

Ticker ARTSX · Since 1995-03-28 · · Holdings as of Jun 30, 2026

Expense ratio
1.25%$125/yr per $10k
5-yr return
−2.7%annualized
1-yr return
+8.3%as of Dec 2025
Net assets
$958.2Mall share classes
Holdings
59

Bottom line

Is ARTSX a good fund? The bottom line

ARTSX is the Investor share class of Artisan Small Cap Fund, a managed small-cap mutual fund from Artisan Partners.

Annual fees run 1.25% — about $125 a year on every $10,000 invested, more expensive than 75% of small-cap funds we track.

It returned +8.3% over one year, −2.7% a year over five years, +10.4% a year over ten (as of Dec 31, 2025, per its prospectus).

With $958 million in net assets and 59 holdings, its largest position is Twist Bioscience Corp. (5.5%) and the top 10 make up 38.3% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.25%)
  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What ARTSX invests in

The Fund seeks long-term capital growth.

The Funds investment team employs a fundamental investment process to construct a diversified portfolio of US small-cap growth companies. The team seeks to invest in companies that it believes possess franchise characteristics, are benefiting from an accelerating profit cycle and are trading at a discount to its estimate of private market value. The Funds investment process focuses on two distinct elementssecurity selection and capital allocation. The team overlays its investment process with sustainability considerations and broad knowledge of the global economy. Security Selection The team seeks to identify companies that have franchise characteristics (e.g., low cost production capability, possession of a proprietary asset, dominant market share or a defensible brand name), are benefiting from an accelerating profit cycle and are trading at a discount to the teams estimate of…

From the fund's prospectus (filed Aug 31, 2026).

ARTSX performance

Fund calendar-year total returns, 2015–2025 2015: +0.3%; 2016: +5.5%; 2017: +26.8%; 2018: +2.3%; 2019: +40.1%; 2020: +61.0%; 2021: −8.9%; 2022: −29.4%; 2023: +9.3%; 2024: +14.7%; 2025: +8.3% +0% 2015 +6% 2016 +27% 2017 +2% 2018 +40% 2019 +61% 2020 −9% 2021 −29% 2022 +9% 2023 +15% 2024 +8% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
ARTSX+8.3%−2.7%+10.4%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full ARTSX performance history →

What ARTSX costs

On a $10,000 investment, ARTSX's 1.25% expense ratio costs about $125 a year. The prospectus estimates $1,511 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full ARTSX fee table →

ARTSX top 10 holdings

#Holding% of fund
1Twist Bioscience Corp.5.55%
2Modine Manufacturing Co.4.96%
3Lattice Semiconductor Corp.4.42%
4Compass, Inc.3.94%
5Cognex Corp.3.64%
6VSE Corp.3.43%
7Ascendis Pharma A/S3.25%
8SPX Technologies, Inc.3.12%
9Marex Group plc3.01%
10Ionis Pharmaceuticals, Inc.2.96%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 38.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to ARTSX

More funds like ARTSX →

ARTSX FAQ

What is the expense ratio of ARTSX?
ARTSX's expense ratio is 1.25%, which works out to about $125 a year for every $10,000 invested. The prospectus estimates total costs of $1,511 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is ARTSX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.25%); 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What does ARTSX hold?
ARTSX's largest holdings are Twist Bioscience Corp. (5.5%), Modine Manufacturing Co. (5.0%), Lattice Semiconductor Corp. (4.4%), Compass, Inc. (3.9%), Cognex Corp. (3.6%). It holds 59 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is ARTSX's 5-year return?
ARTSX returned −2.7% a year over the five years ending Dec 31, 2025, and +10.4% a year over ten years. Past performance does not guarantee future results.
Does ARTSX have a sales load?
No. ARTSX has no front-end sales charge.
Who manages ARTSX?
ARTSX is offered by Artisan Partners through Artisan Partners Funds Inc.